Ouhua Holding Group

Ouhua Holding Group is a diversified Chinese conglomerate with a primary focus on the life sciences sector through its flagship subsidiary, Zhejiang Ouhua Pharmaceutical. Established in 1998, the company has grown into a leading manufacturer of active pharmaceutical ingredients (APIs) and finished dosage forms, specializing in macrolide antibiotics. Its core product line includes widely used anti-infectives such as Clarithromycin, Azithromycin, and Roxithromycin, which are distributed to both domestic and international markets. The group operates state-of-the-art manufacturing facilities that hold certifications from major regulatory bodies, including the US FDA and European authorities, ensuring high-quality standards for global supply. In addition to its pharmaceutical core, Ouhua Holding Group maintains strategic interests in chemical production and international trade to support its vertically integrated business model.